IUSV ETF Factor Report

The iShares Russell 3000 Value ETF (IUSV) is characterized as a large-cap, low volatility ETF, with its primary sector allocation in Financials and largest industry exposure in Biotechnology & Drugs. A factor analysis reveals strong exposure to low volatility (score 85) and moderate exposure to value (64) and quality (60), while exhibiting low momentum (19).

Analysis

The iShares Russell 3000 Value ETF (IUSV) is characterized as a large-cap, low volatility exchange-traded fund, as detailed in Validea's fundamental report. Its portfolio exhibits significant concentration in the Financial sector, while its largest industry exposure is within Biotechnology & Drugs.

A detailed factor analysis reveals IUSV's strong alignment with its low volatility mandate, scoring 85 out of 99 in this factor. The ETF also demonstrates moderate exposure to value and quality factors, with scores of 64 and 60 respectively.

Conversely, IUSV shows very low exposure to momentum, registering a score of just 19. This indicates the ETF is not heavily weighted towards securities that have recently outperformed, which is a critical consideration for investors focused on recent price trends.

This factor profile positions IUSV as a potentially defensive allocation within a large-cap value framework, emphasizing stability over recent growth trends. The neutral sentiment and low market impact suggest this report provides foundational insights rather than immediate market catalysts.

Key Decisions for Investors

• Investors seeking defensive large-cap exposure with a focus on stability should consider IUSV given its high low-volatility factor score of 85.
• Those prioritizing recent price momentum should note IUSV's very low momentum score of 19, indicating a lack of exposure to recent outperformers.
• Portfolio managers should assess IUSV's significant allocation to the Financial sector and Biotechnology & Drugs industry for potential concentration risks or benefits within their existing holdings.